Skip to main content

Kidney Stones and Chronic Kidney Disease

  • Chapter
  • First Online:
Book cover Urolithiasis

Abstract

Chronic kidney disease has become a global public health problem with serious social and economic effects from premature morbidity and deaths. Kidney stone formers are at increased risk for chronic kidney disease (CKD)—both early and advanced stages—with the stone acting either as the initiating or a contributing factor. Recent data indicates that prevalence and incidence of kidney stone are increasing worldwide. Individuals with kidney stones should be screened for the presence of underlying CKD. This chapter reviews the burden of CKD, the risk of kidney stone formation, and the association of CKD with kidney stones and underscores the need for screening and preventive strategies for CKD in individuals with kidney stones.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hemmelgarn BR, Manns BJ, Lloyd A, James MT, Klarenbach S, Quinn RR, et al. Alberta kidney disease network. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010;303(5):423–9.

    Article  PubMed  CAS  Google Scholar 

  2. Remuzzi G. A research program for COMGAN. ISN News. July 2001:1–6.

    Google Scholar 

  3. Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A. US renal data system 2010 annual data report. Am J Kidney Dis. 2011;57(1 Suppl 1):A8, e1–526.

    Article  PubMed  Google Scholar 

  4. Jafar TH. The growing burden of chronic kidney disease in Pakistan. N Engl J Med. 2006;354:995–7.

    Article  PubMed  CAS  Google Scholar 

  5. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354:997–9.

    Article  PubMed  CAS  Google Scholar 

  6. Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012;379(9811):165–80.

    Article  PubMed  Google Scholar 

  7. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108:2154–69.

    Article  PubMed  Google Scholar 

  8. Alsuwaida AO, Farag YM, Al Sayyari AA, Alhejaili F, AlHarbi A, Houswi A. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (Seek Saudi Investigators). Saudi J Kidney Dis Transpl. 2010;21:1066–72.

    PubMed  Google Scholar 

  9. Husseinpanah F, Kasraei F, Nassiri AA, Azizi F. High prevalence of kidney disease in Iran: a large population based study. BMC Public Health. 2009;9:44.

    Article  Google Scholar 

  10. Ingsathit A, Thakkiinstian A, Chaipraset A, Sangthawan P, Sangthawan P, Gojaseni P, et al. Prevalence and risk factors for chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25:1567–75.

    Article  PubMed  Google Scholar 

  11. Rule A, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011;6:2069–75.

    Article  PubMed  Google Scholar 

  12. Curhan GC. Epidemiology of stone disease. Urol Clin North Am. 2007;34:287–93.

    Article  PubMed  Google Scholar 

  13. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int. 2003;63:1817–23.

    Article  PubMed  Google Scholar 

  14. Johnson CN, Wilson DM, O’Fallen WM, Malek RS, Kurland RT. Renal stone epidemiology: a 25 years study in Rochester Minnesota. Kidney Int. 1979;16:624–31.

    Article  PubMed  CAS  Google Scholar 

  15. Lieske JC, de la Pena Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KI, et al. Renal stone epidemiology in Rochester, Minnesota. An update. Kidney Int. 2006;69:760–4.

    Article  PubMed  CAS  Google Scholar 

  16. Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney Int. 1994;46:893–9.

    Article  PubMed  CAS  Google Scholar 

  17. Robertson WG. Epidemiology of urinary stone disease. Urol Res. 1990;18 Suppl 1:S3–8.

    Article  PubMed  Google Scholar 

  18. Johri N, Jaeger P, Robertson W, Choong S, Unwin R. Renal stone disease. Medicine. 2011;39(7):371–7.

    Article  Google Scholar 

  19. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol. 2000;13 Suppl 3:S45–50.

    PubMed  Google Scholar 

  20. Romero V, Akpinar H, Assimos DG. Kidney stone: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12:e86–96.

    PubMed  Google Scholar 

  21. Yoshida O, Okada Y. Epidemiology of urolithiasis in Japan: a chronological and geographical study. Urol Int. 1990;45(2):104–11.

    Article  PubMed  CAS  Google Scholar 

  22. Yanagaw M, Kawamura J, Onishi T, Soga N, Kameda K, Sriboonlue V, et al. Incidence of urolithiasis in northeast Thailand. Int J Urol. 1997;4(6):537–40.

    Article  Google Scholar 

  23. Jungers P, Joly D, Barbey F, Choukroun G, Daudon M. ESRD caused by nephrolithiasis: prevalence, mechanism, and prevention. Am J Kidney Dis. 2004;44:799–805.

    PubMed  Google Scholar 

  24. Stankus N, Hammes M, Gillen D, Worcester E. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res. 2007;35(2):83–7. Epub 2007 Feb 20.

    Article  PubMed  Google Scholar 

  25. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005;67(2):685–90.

    Article  PubMed  Google Scholar 

  26. Gooneratne IK, Ranaweera AK, Liyanarachchi NP, Gunawardane N, Lanerolle RD. Epidemiology of chronic kidney disease in Sri Lankan population. Int J Diabetes Dev Ctries. 2008;28:60–4.

    Article  PubMed  CAS  Google Scholar 

  27. Abboud OL, Osman EM, Musa AR. The etiology of chronic renal failure in adult Sudanese patients. Ann Trop Med Parasitol. 1989;83:411–4.

    PubMed  CAS  Google Scholar 

  28. Sitiprija V. Nephrology in south east Asia: fact and concept. Kidney Int. 2003;63(S83):s128–30.

    Article  Google Scholar 

  29. Afshar R, Sanavi S, Salimi J. Epidemiology of chronic renal failure in Iran: a four year single center experience. Saudi J Kidney Dis Transplant. 2007;18:191–4.

    Google Scholar 

  30. Daudon M. Epidemiology of nephrolithiasis in France. Ann Urol (Paris). 2005;39:209–31.

    Article  CAS  Google Scholar 

  31. Safaraninejad MR. Adult urolithiasis in a population bases study in Iran: prevalence, incidence, and associated risk factors. Urol Res. 2007;35:73–82.

    Article  Google Scholar 

  32. Rizvi SAH, Manzoor K. Causes of chronic renal failure in Pakistan: a single large center experience. Saudi J Kidney Dis Transplant. 2002;13:376–9.

    Google Scholar 

  33. Frick KK, Bushinsky DA. Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol. 2003;14:1082–95.

    Article  PubMed  Google Scholar 

  34. Scheinman SJ. Nephrolithiasis. Semin Nephrol. 1999;19:381–8.

    PubMed  CAS  Google Scholar 

  35. Robertson WG, Peacock M, Marshall RW, Speed R, Nordin BE. Seasonal variations in the composition of urine in relation to calcium stone-formation. Clin Sci Mol Med. 1975;49:597–602.

    PubMed  CAS  Google Scholar 

  36. Moe OW, Bonny O. Genetic hypercalciuria. J Am Soc Nephrol. 2005;16:729–45.

    Article  PubMed  Google Scholar 

  37. Parry ES, Lister IS. Sunlight and hypercalciuria. Lancet. 1975;1:1063–5.

    Article  PubMed  CAS  Google Scholar 

  38. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol. 1997;8:1568–73.

    PubMed  CAS  Google Scholar 

  39. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833–8.

    Article  PubMed  CAS  Google Scholar 

  40. Serio A, Fraioli A. Epidemiology of nephrolithiasis. Nephron. 1999;81 suppl 1:26–30.

    Article  PubMed  Google Scholar 

  41. Fakheri RJ, Goldfarb DS. Ambient temperature as a contributor to kidney stone formation: implications of global warming. Kidney Int. 2011;79(11):1178–85.

    Article  PubMed  Google Scholar 

  42. Resnick M, Pridgen DB, Goodman HO. Genetic predisposition to formation of calcium oxalate renal calculi. N Eng J Med. 1968;278:1313–8.

    Article  CAS  Google Scholar 

  43. Ljunghall S, Danielson BG, Fellström B, Holmgren K, Johansson G. Family history of renal stones in recurrent stone patients. Br J Urol. 1985;57(4):370–4.

    Article  PubMed  CAS  Google Scholar 

  44. Pishchalnikov YA, McAteer JA, Williams Jr JC, et al. Why stones break better at slow shockwave rates than at fast rates: in vitro study with a research electrohydraulic lithotripter. J Endourol. 2006;20(8):537–41.

    Article  PubMed  Google Scholar 

  45. Connors BA, Evan AP, Blomgren PM, et al. Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJU Int. 2009;104(7):1004–8.

    Article  PubMed  Google Scholar 

  46. Bander SJ, Buerkert JE, Martin D, Klahr S. Long-term effects of 24-h unilateral ureteral obstruction on renal function in the rat. Kidney Int. 1985;28:614.

    Article  PubMed  CAS  Google Scholar 

  47. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.

    Article  PubMed  CAS  Google Scholar 

  48. Curhan GC, Willett WC, Speizer FE, et al. Beverage use and risk for kidney stones in women. Ann Intern Med. 1998;128(7):534–40.

    PubMed  CAS  Google Scholar 

  49. Siener R, Ebert D, Nicolay C, et al. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int. 2003;63(3):1037–43.

    Article  PubMed  Google Scholar 

  50. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.

    Article  PubMed  CAS  Google Scholar 

  51. Fink HA, Akornor JW, Garimella PS, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009;56(1):72–80.

    Article  PubMed  Google Scholar 

  52. Hesse AT, Tiselius H-G, Siener R, Hoppe B, editors. Urinary stones, diagnosis, treatment and prevention of recurrence. 3rd ed. Basel: S Karger AG; 2009.

    Google Scholar 

  53. Stitchantrakul W, Sopassathit W, Prapaipanich S, et al. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake. Southeast Asian J Trop Med Public Health. 2004;35(4):1028–33.

    PubMed  CAS  Google Scholar 

  54. von Unruh GE, Voss S, Sauerbruch T, et al. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004;15(6):1567–73.

    Article  Google Scholar 

  55. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980;128:439–50.

    Article  PubMed  CAS  Google Scholar 

  56. Sarig S. The hyperuricosuric calcium oxalate stone former. Miner Electrolyte Metab. 1987;13(4):251–6.

    PubMed  CAS  Google Scholar 

  57. Ettinger B. Hyperuricosuric calcium stone disease. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM, editors. Kidney stones: medical and surgical management. Philadelphia: Lippincott-Raven; 1996. p. 851–8.

    Google Scholar 

  58. Constanzo LS, Windhager EE. Calcium and sodium transport by the distal convoluted tubule of the rat. Am J Physiol. 1978;235(5):F492–506.

    Google Scholar 

  59. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med. 2001;135:73–87.

    PubMed  CAS  Google Scholar 

  60. Jafar TH, Paul C, Stark PC, Schmid CH, Landa M, Maschio G, et al. Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med. 2003;139:244–52.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tazeen H. Jafar M.D., MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Ali, A., Khan, Q., Jafar, T.H. (2012). Kidney Stones and Chronic Kidney Disease. In: Talati, J., Tiselius, HG., Albala, D., YE, Z. (eds) Urolithiasis. Springer, London. https://doi.org/10.1007/978-1-4471-4387-1_74

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4387-1_74

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4383-3

  • Online ISBN: 978-1-4471-4387-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics